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Supercentenarians (age 110+ years old) generally delay or escape age-related diseases and
disability well beyond the age of 100 and this exceptional survival is likely to be inﬂuenced
by a genetic predisposition that includes both common and rare genetic variants. In this
report, we describe the complete genomic sequences of male and female supercentenar-
ians, both age >114 years old. We show that: (1) the sequence variant spectrum of these
two individuals’ DNA sequences is largely comparable to existing non-supercentenarian
genomes; (2) the two individuals do not appear to carrymost of thewell-established human
longevity enabling variants already reported in the literature; (3) they have a comparable
number of known disease-associated variants relative tomost human genomes sequenced
to-date; (4) approximately 1% of the variants these individuals possess are novel and may
point to new genes involved in exceptional longevity; and (5) both individuals are enriched
for coding variants near longevity-associated variants that we discovered through a large
genome-wide association study.These analyses suggest that there are both common and
rare longevity-associated variants that may counter the effects of disease-predisposing
variants and extend lifespan. The continued analysis of the genomes of these and other
rare individuals who have survived to extremely old ages should provide insight into the
processes that contribute to the maintenance of health during extreme aging.
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INTRODUCTION
Human aging is affected by genes, life style, and environmental
factors. The genetic contribution to average human aging can
be modest with genes explaining ∼20–25% of the variability of
human survival to the mid-eighties (Herskind et al., 1996; Fraser
and Shavlik, 2001). By contrast, genetic factors may have greater
impact on survival to the ninth through eleventh decades (Tan
et al., 2008). Notably, exceptional longevity is rare and may involve
biological mechanisms that differ from those implicated in usual
human aging.
The nature and contribution of genetic variation to excep-
tional longevity remains unclear, particularly the role for undis-
covered rare genetic variants with large effects and/or the pres-
ence of many common genetic variants with small effects (Bloss
et al., 2010). Exceptional longevity is typically characterized by
strong familiality (Perls et al., 2000, 2002; Atzmon et al., 2005;
Schoenmaker et al., 2006) as well as a marked delay in disabil-
ity (Terry et al., 2008) and, as human lifespan is approached at
about age 110 years, many such individuals compress not only
disability but also age-related diseases (Andersen et al., 2011).
Studies of centenarians have provided strong evidence to sup-
port the hypothesis that a genetic contribution to human excep-
tional longevity is decisive, although only a small number of
genetic variants with modest effects have been irrefutably linked
to this phenotype (Schachter et al., 1994; Barzilai et al., 2003;
Christensen et al., 2006; Wheeler and Kim, 2011). The tech-
nology of next generation sequencing provides a tool to gen-
erate data that may eventually provide an answer (Metzker,
2009).
In this report, we describe the complete DNA sequences of two
supercentenarians, a male and a female, both ages>114 years old.
Although these data cannot provide conclusive evidence about the
genetic determination of human exceptional longevity, they are
the ﬁrst step toward the generation of a comprehensive reference
panel of exceptionally long-lived individuals. Thedata also provide
interesting insights into genetic backgrounds that are conducive
to exceptional longevity and allow us to test different models of
exceptional longevity.
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RESULTS
SUBJECTS’ CHARACTERISTICS
Figure 1 shows some of the characteristics of the two subjects,
PG17 (female) and PG26 (male).We are purposefully vague about
the exact ages of these individuals to maintain their conﬁdential-
ity and decrease the risk of their being identiﬁed. Both individuals
were Caucasians enrolled in the New England Centenarian Study
(NECS), andwere reassessed annually until their deaths (Andersen
et al., 2011). Their European ancestry was veriﬁed by genome-
wide principal component analysis. They were selected for our
sequencing study because of their exceptional lifespans and health
histories, and the extreme delays in the ages of onset of disability
that they exhibited. The bottom panel of Figure 1 shows the aver-
age scores of cognitive and physical functions of the female (PG17)
and the male (PG26) relative to trajectories of cognitive and func-
tional declines that we generated using longitudinal data of more
than 1,300 centenarians and their nonagenarian siblings (Ander-
sen et al., 2011). While the decline of physical function of the
female matches the average trend of supercentenarians enrolled
in the NECS (n = 104), the male maintained functional inde-
pendence until at least the last 6months of his life. The average
Blessed Information–Memory–Concentration Test scores (mea-
sures of cognitive function) of both subjects were higher than the
average of the NECS supercentenarian sample, until their deaths.
Themanhad substantial longevity in his family; 25%of his siblings
lived past the age of 100 and 50% lived past the age of 90 years.
Unfortunately we did not have complete information about the
family history of the woman.
DESCRIPTION OF THE DNA SEQUENCING
DNA from both individuals was sequenced using the Illumina
Genome Analyzer II by Illumina’s Clinical Laboratory Service,
using paired-end reads of 100 bp producing 1,650,463,996 reads
for the woman and 1,804,595,182 reads for the man. Reads were
mapped to the genome reference NCBI36 and NCBI37 using
the procedures described in Figure A1 in Appendix. Both ref-
erence genomes were used because some databases have not yet
completed the transition to NCBI37. The Eland aligner (Bent-
ley et al., 2008) mapped more than 75% of the reads for the
woman and more than 79% of the reads for the man with 95–
96% rates of genome coverage. Both the rates of mapped reads
and genome coverage are comparable to others reports (Wang
et al., 2008; Kim et al., 2009). The average depth of coverage was
36 for the woman and 43 for the man (Table A1 in Appendix)
and it was higher than the average of 30× recommended by the
manufacturer1. We also used the BWA aligner (Li and Durbin,
2009) with more relaxed thresholds on the number of allowed
mismatched per read, and aligned 1,334,406,235 reads for the
woman (80.85%), 1,559,315,652 reads for the man (86.41%) and
reached 99% genome coverage. Average depth of coverage with
BWA was 47 for the woman and 55 for the man. The results
from the two aligners were used for variant calling as explained
next.
1http://www.illumina.com/Documents/products/technotes/technote_snp_caller_
sequencing.pdf
FIGURE 1 | Summary of patients’ characteristics. (A)The woman (PG17)
had no medical history other than the births of her children until her early
nineties when she had cataracts removed. She did not develop the listed
diseases until the last few years of her life. Except for the surgically cured
obstructing but non-metastatic colon cancer in his seventies, the man
(PG26) was exceptionally healthy until the last year of his life. Ancestry
was conﬁrmed by genome-wide PCA analysis. (B) Average functional and
cognitive status of the two subjects relative to other NECS subjects
(M=PG26 and F=PG17). The trajectories of physical and cognitive
functional declines were computed using Bayesian logistic regression of
Barthel and Blessed score as explained in Andersen et al. (2011) and for
each age group they are truncated by the maximum age for their deﬁned
age ranges (e.g., 99 years for nonagenarians, 104 for centenarians, 109 for
semi-supercentenarians, and 119 for supercentenarians).
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VARIANT CALLING (SNPs AND INDELS)
Single nucleotide polymorphisms (SNPs) were called using the
Illumina CASAVA (Bentley et al., 2008) software and SAMTools
(Li et al., 2009). The CASAVA algorithm called 3,334,819 SNPs
for the woman and 3,476,407 SNPs for the man, while SAMTools
called 3,613,388 SNPs for the woman and 3,659,978 for the man.
3,084,838 SNPs for the woman and 3,255,051 SNPs for the man
were called by both SNP callers with >99% concordant geno-
type calls, and these SNPs were used in all subsequent analyses
(Figure 2A). The use of concordant SNP calls between the two
methods does risk limiting the true SNP discovery rate but min-
imizes the false discovery rate and also helps remove low quality
SNP calls. Figure A2A in Appendix displays the number of SNPs
by chromosome called by both SNP callers. The male subject had a
consistently larger number of SNPs than the female subject in each
chromosome, with the exception of chromosome X. Figure A2B
in Appendix displays the distribution of Phred scores calculated
with SAMTools for the SNPs with consensus call. Figure A2C
in Appendix displays the distribution of reads coverage used for
SNP calling with CASAVA for the SNPs with consensus call. Both
Figures A2B,C in Appendix show high quality SNPs.
The two subjects shared 1,997,897 SNPs, and 66%of these SNPs
had the same genotypes (Figure 2A). Comparisonwith dbSNP132
and the 1000 Genomes database2 showed that 97.6 and 97.5% of
SNPs in the female and the male subjects were in dbSNP, and up to
99.7% of the SNPs in common between the two subjects were in
2http://www.1000genomes.org/
dbSNP. Only 1% of the SNPs in both individuals’ sequences were
reported in the 1000 Genomes database but not in dbSNP, and
2,590 of these SNPs were shared between the two subjects, 81% of
which with the same genotypes. 44,713 SNPs in the woman and
48,725 SNPs in the man were neither in dbSNP nor in the 1000
Genomes database, and were therefore labeled“novel.”Only 2,254
of these novel SNPs were shared between the two subjects, and
73% of these were called with the same genotypes. Figure 2 sum-
marizes these ﬁndings. The decreasing trend of shared SNPs that
were either in the 1000 Genomes database or novel is consistent
with these SNPs being rare in the population.
The number of called SNPs in the man and the fraction of
novel SNPs in both subjects were consistent with the projections
made by The 1000 Genomes Project Consortium (2010). The
number of SNPs in the woman was smaller than the expected
3.3 million, and to investigate this issue further, we used SNP
array data generated with the Illumina 610 array to describe the
genome-wide structure of chromosomal alterations in thewoman.
The analysis showed that her genome was characterized by sig-
niﬁcant stretches of homozygosity across many chromosomes
(Figure A3 in Appendix). These runs of homozygosity might be
consistent with inbreeding amongst her ancestors (Nalls et al.,
2009). The same analysis in the man showed no similar stretches
of homozygosity (Figure A4 in Appendix).
For additional assessment of the quality of the data, we com-
puted the concordance between genotype calls in the sequences
of the two subjects and their SNP array data. For both subjects,
the concordance between genotype calls of SNPs in the array and
SNPs in the sequences was >99.7%. In addition, more than 98%
FIGURE 2 | (A) Summary of SNPs and small insertions and deletions (Indels)
detected in the two sequences, their union and intersection. The January
2011 release of the 1000 Genomes was used to compare the SNPs detected
in the two sequences that were not found in dbSNP. (B) Venn diagram that
illustrates the proportion of known and novel SNPs in the woman (PG17) and
man (PG26) combined. (C) Distribution of effective coverage (reads used to
call genotypes in CASAVA) for novel SNPs. (D) Distribution of Phred scores
for the novel SNPs. The Phred scores were computed with BWA/SAMTools.
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of the SNPs in the array not included in the list of called SNPs from
the sequencing were homozygous for the referent allele. Transition
to transversion ratios (2.11 in the man and 2.07 in the woman)
were consistent with the expected number in Caucasians (Ebers-
berger et al., 2002), and comparable to other Caucasian genomes
(see Tables A2–A4 in Appendix; Drmanac et al., 2009; The 1000
Genomes Project Consortium, 2010) and also to genomes from
other racial groups (Wang et al., 2008; Kim et al., 2009; Moore
et al., 2011). The transition to transversion ratio of the novel SNPs
was comparable to the whole set (2.12 in the woman and 2.05 in
the man), while the transition to transversion ratio in the SNPs
that were reported only in the 1000 Genomes was slightly higher
(TableA4 inAppendix). The rates of heterozygous to homozygous
genotypes were 1.41 in the man and 1.24 in the woman. While the
heterozygous to homozygous genotypes ratio of the woman was
identical to that found in the whole genome sequence of Craig
Venter (Levy et al., 2007; Table A3 in Appendix), the heterozygote
to homozygote ratio in the man was higher but comparable to
values in other whole genome sequences (Moore et al., 2011). The
heterozygous to homozygous ratio of novel SNPs ranged between
6.3 and 9.2, while the heterozygous to homozygous ratio of SNPs
discovered in the 1000 Genomes was 7.12 in the woman and 14.6
in the man. This higher ratio is consistent with novel SNPs being
much rarer. Figure A5, A6 in Appendix show that these rates are
robust to different thresholds for depth of coverage.
We used both SAMTools and Dindel (Albers et al., 2011) to call
small insertions and deletions (Indels) as described in the Meth-
ods, and selected only those indels that were detected by both
algorithms, had a Phred score of 30 or higher, and passed the
default quality ﬁlters in Dindel. Figure A7 in Appendix shows
the distribution of coverage and Phred scores for the Indels
that passed the quality control ﬁlters. Both subjects were carri-
ers of a number of insertions and deletions that is comparable
to other published results of Caucasian genomes (Table A4 in
Appendix).
FUNCTIONAL ANNOTATION
We used a suite of bioinformatics tools assembled and built by
researchers at The Scripps Research Institute (Torkamani et al.,
2011) to characterize SNPs and Indels by location, functional role,
and predicted impact. Figure 3A gives a summary of SNP loca-
tions and functional roles. Approximately 37% of the positions
where the two subjects differed from the reference genome were in
protein coding genes, but only about 2% of these positions were
coding SNPs, and less than 50% of these coding SNPs were non-
synonymous or missense variants. The rate of non-synonymous
SNPs in coding regions was similar to other genomes (Figure 3B).
The rate of coding SNPswas comparable to the average rate in nine
European ancestry whole genome sequences generated at Com-
plete Genomics (unpublished data provided to author Nicholas
J. Schork but available for download at: http://www.complete
genomics.com/sequence-data/download-data/) and higher than
the rate observed in thewhole genome of Venter or non-Caucasian
genomes (AK, CH, and YRI) based on published data (Figure 3B
and Kim et al., 2009). The distribution of types of coding variants
was not different from the nine Complete Genomics genomes
FIGURE 3 | (A) functional annotation of SNPs in PG17 (female), PG26 (male),
their union and intersection. Multiple transcripts of the same genes were
counted individually. (B) Rate of non-synonymous SNPs in coding SNPs in
PG17 and PG26 (brown) and other whole genome sequences generated at
Complete Genomics (orange), Sanger (green), and Illumina (blue). CG (9
CEPH) is the average rate of non-synonymous SNPs in nine whole genome
sequences generated at Complete Genomics. The rates of non-synonymous
SNPs in Venter (green), AK, CH, andYRI (blue) are from publications (see
Table A2 in Appendix for references). (C,D) Compare the distribution of SNPs
locations and role in PG17 and PG26 (brown) and nine whole genome
sequences generated at Complete Genomics (orange). (E) Provides a
summary of the predicted impact of coding SNPs in PG17, PG26, their union
and intersection, and the summary in nine Caucasians genotyped at complete
genomics and annotated in the same way as PG17 and PG26.
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that were annotated in the same manner (Figures 3C,D). The
inferred rates of SNPs with deleterious effects were also not dif-
ferent from the rates noted in the nine whole genomes sequences
(Figure 3E). We conducted a similar analysis of small insertions
and deletions and the results are summarized in Figures A8 and
A9 in Appendix.
DIFFERENT GENETIC MODELS OF EXCEPTIONAL LONGEVITY
We used the whole genome sequences of these two subjects to test
different hypotheses about the genetics of exceptional longevity.
These non-exclusive hypotheses and the results of the analyses are
described in the sections that follow.
Hypothesis 1: the “metabolic” hypothesis
Genes involved in the insulin pathway (Guarente and Kenyon,
2000; Kops et al., 2002; Bonafe et al., 2003; Holzenberger et al.,
2003; Lee et al., 2003; Kojima et al., 2004; Al-Regaiey et al., 2005;
Arai et al., 2008; Suh et al., 2008; Willcox et al., 2008; Paw-
likowska et al., 2009), caloric restriction (Kuro-o et al., 1997;
Vaziri et al., 2001; Arking et al., 2002; Chua et al., 2005; Kurosu
et al., 2005; Kuningas et al., 2007), and lipid metabolism (Barzi-
lai et al., 2003, 2006) have notable impacts upon lifespan and
therefore have been a natural focus for consideration in inves-
tigating the genetic basis of exceptional longevity. We compiled
a table of 16 variants that have been associated with excep-
tional longevity in candidate gene studies based on evidence
from animal models of aging and related pathways (Table 1A).
This compilation was not intended to be comprehensive, but
rather an initial attempt at testing the hypothesis. The entire
sequences of the two subjects will be posted on dbGaP3 so that
3http://www.ncbi.nlm.nih.gov/gap
Table 1 | (A) List of SNPs that were linked to aging and exceptional longevity in the literature based on candidate gene studies and/or animal
models. Columns 5–7 deﬁne the referent allele (Ref Allele), the allele that was associated with longevity (EL Allele), and the frequency of the longevity
allele in Caucasians from dbSNP. Boldface highlights genotypes with one or more longevity variants. (B) All additional coding SNPs in the list of candidate
genes in which PG17 or PG26 carry non-referent alleles. Column 7 (CEU) reports the frequency of the referent alleles in Caucasians from dbSNP.
A. Coding SNPs linked to exceptional longevity in published literature
SNP HG18 Alleles Ref Allele EL Allele p (EL allele) Pubmed PG17 PG26
FOXO3A rs12206094 chr6:109012893 C/T C T 0.27 CC TT
rs2764264 chr6:109041154 C/T C C 0.29 TT CC
rs7762395 chr6:109051800 A/G G A 0.17 20849522 GG AA
rs9400239 chr6:109084356 C/T T T 0.24 CC TT
rs479744 chr6:109126725 G/T G T 0.20 GG TT
IGF1R rs2229765 chr15:97295748 G/A G A 0.42 12843179 AG AA
rs34516635 chr15:97269499 G/A G A 0.02 GG GG
chr15:97068418 G/A G A 18316725 GG GG
chr15:97272104 G/A G A GG GG
HSP70 rs2227956 chr6:31886251 G/A G A 0.76 PMC1576475 AA AA
CETP rs5882 chr16:55573593 A/G G GG 0.36 20068209 AA AA
PON1 rs662 chr7:94775382 T/C T C 0.33 15050299 CT TT
MINPP1 rs9664222 chr10:89338633 A/C A C 0.76 20304771 CC AC
SIRT1 Rs3758391 chr10:69313348 C/T T T 0.27 17895433 CC CT
Klotho rs9536314 chr13:32526138 T/G T G 0.14 11792841 GT GT
rs9527025 chr13:32526193 G/C G C 0.19 CG CG
B. Additional coding SNPs in genes linked to exceptional longevity
Gene SNP HG18 Alleles Ref EL Allele CEU Impact PG17 PG26
SIRT1 rs2273773 chr10:69336604 C/T T T 0.96 Syn TT CT
SIRT3 rs28365927 chr11:226091 A/G G G 0.85 Non-syn AG GG
klotho rs2772364 chr13:32488851 C/T T C 1.00 Syn CC TT
rs9527026 chr13:32526239 A/G G G 0.83 Syn AG AG
rs564481 chr13:32532983 C/T C C 0.63 Syn CT CT
rs648202 chr13:32533463 C/T T C 0.85 Syn CC CC
rs649964 chr13:32533835 C/T T C 1.00 Syn CC CC
IGF1R rs35812156 chr15:97252339 A/C C C 0.98 Syn AC CC
SIRT6 rs352493 chr19:4131836 C/T C T 0.96 Non-syn CT TT
SIRT5 rs3757261 chr6:13707282 C/T C C 0.73 Syn CT CT
P ON1 rs854560 chr7:94784020 A/T A A 0.59 Non-syn AA TT
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investigators can investigate other candidate genes, especially those
that receive attention in the future after our analyses have been
published.
The woman was homozygous for only one of the 16 longevity
variants (allele A of rs2227956 in HSP70), and heterozygous for 4
others. The man was homozygous for seven longevity variants
and heterozygous for four. Neither of the two sequences car-
ried the longevity-associated variant of CETP that was found in
Ashkenazi Jewish centenarians (Barzilai et al., 2003). The man car-
ried a cluster of longevity variants in FOXO3A, but the woman
did not, and only one longevity variant in IGF1R was found
in both subjects. Both carried the same genotypes of rs9536314
and rs9527025 in KL. We also examined additional coding SNPs
in the candidate genes in which the two subjects carried differ-
ent alleles from the reference genome (Table 1B). Eleven addi-
tional SNPs were found in metabolic genes (IGF1R, Sirtuins
genes, KL, and PON1) but no additional SNPs were found in
FOXO3A. All of the variants in Table 1 carried by PG17 and
PG26 were common in Caucasians, with the exclusion of the
T allele of SNP rs2772364 in KL in the man. Whether these
additional SNPs are present in the cited studies but were not
reported is unknown. The different genetic proﬁles of these can-
didate genes in the two supercentenarians suggest that even if the
variants in Table 1A may have a role in longevity they are not
critical to exceptional longevity in all humans. Additionally, the
impact of these variants must be considered within the context
of other as of yet undiscovered longevity- and disease-associated
variants.
Hypothesis 2: the lack of disease-associated variants hypothesis
As noted earlier, both subjects markedly delayed both disability
and age-related diseases until very late in their lives. We tested
the hypothesis that these two whole genome sequences did not
include disease-predisposing variants or, if they did, the number
was signiﬁcantly lower compared to currently available genomes.
We compiled a list of 62,339 disease-annotated variants from the
Human Genome Mutation Database (HGMD@; Stenson et al.,
2009), which are mainly rare variants, and the NHGRI GWAS cat-
alog (Hindorff et al., 2011),which contains both rare and common
disease-associated variants. This list included 100 variants with
presumed protective effects, and 62,239 with presumed deleteri-
ous effects. We then assessed how many of these disease variants
were in the two sequences. Table S1 in Supplementary Material
reports the list of disease-annotated variants in each subject.
Figure 4A shows that while the two sequences include only
1% of mutations from the HGMD, they include approximately
50% of the mutations that were linked to common diseases in
genome-wide association studies. More than 50% of all the noted
mutations were heterozygous, but this number was smaller when
we only considered coding mutations from the HGMD. Figure 4B
shows the breakdown of these variants by disease group and by
role: (1) either damaging, if they are associated with increased
risk for disease, or (2) protective if the mutations are known to
decrease disease risk relative to the general population. Only 1%
of known disease-annotatedmutations in thewomanwere protec-
tive, while 2% of known disease-annotated mutations in the man
were protective. The woman carried at least 30 mutations that
FIGURE 4 | (A) Summary of SNPs associated with disease in the HGMD
and the GWAS catalog, and number of these SNPs and rates found in
PG17 and PG26. (B) Number of SNPs in PG17 and PG26 that have either
a known protective or deleterious role in major age-related diseases. (C)
The bar plot shows the rate of disease-annotated variants in PG17 and
PG26 and 11 other whole genome sequences.We did not include in this
analysis the genomes of NA12878 and NA18507 that were sequenced
with SOLID. Blue: all SNPs from HGMD and GWAS; red: only coding
SNPs from HGMD; green: only SNPs from GWAS. Rates are per 100,000
SNPs. (D). Rate of protective variants in PG17 and PG26 and 11 other
whole genome sequences. The major difference seems to be race
related rather than subject related.
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were linked to Alzheimer’s disease and amyotrophic lateral scle-
rosis and one mutation linked to decreased risk for Alzheimer’s
disease (CT genotype for rs2736911 in ARMS2, Gatta et al., 2008),
201mutations associatedwith cancer, including 27 associatedwith
increased risk for breast cancer andonemutationwith reduced risk
for breast cancer (GG genotype of rs2295283 in MIIP ; Song et al.,
2010), 44 associated with lung cancer, and 30 associated with col-
orectal cancer. She also carried 52 mutations associated with heart
disease, 136 associated with diabetes, 12 linked to macular degen-
eration that she was diagnosed with after the age of 100 years.
The man carried 37 mutations associated with increased risk for
colon cancer, including severalmutations in EXO1. Indeed, he pre-
sented with an obstructing colon cancer (adenocarcinoma) in his
mid-seventies that was cured by surgical resection but amazingly
there were no metastases despite the size of the obstructing mass.
His load of disease-predisposing variants was comparable to the
female subject. For example, he had 44 mutations associated with
lung cancer, and 33 mutations associated with Parkinson’s disease.
Regarding the APOE alleles, the male subject was heterozygous
for SNP rs7412 in APOE and homozygous TT for SNPrs429358
in APOE and therefore he carried the ε2/ε3 alleles of APOE that
are considered at less risk for Alzheimer’s disease. The woman
was homozygous for both rs7412 and rs429358, and therefore she
carried ε3/ε3 alleles of APOE which is considered the neutral allele.
The bar plot in Figure 4C shows the rate of disease-associated
variants in both subjects and 11 additional genomes described
in Moore et al. (2011) and The 1000 Genomes Project Consor-
tium (2010), normalized to the overall number of variants used
in each genome. Although the actual number of variants may
depend on the sequencing technology and mapping algorithm,
the rates normalized to the overall number of called SNPs should
allow for relative comparisons. We observed no reduction in the
rate of disease-annotated variants in the woman and man com-
pared to the Venter and Watson genomes, and even higher rates
compared to the high coverage trio of Caucasians included in
the 1000 Genomes project (NA12891, NA12892, and NA12878).
The major differences appear to be race-speciﬁc, with subjects
of African ancestry carrying a smaller rate of disease-annotated
variants (either protective or damaging) compared to Asians and
Caucasians. These differences may be ancestral differences or they
might reﬂect the better knowledge of genetic variants in Cau-
casians (Lohmueller et al., 2008). We also examined the rate of
protective variants in the 13 genomes (Figure 4D) and, although
the rate of known protective variants in PG26 was higher than in
PG17, it was smaller than in NA07022. The genome of NA07022
was sequenced at Complete Genomics and the overall number of
called variants was similar to that found in PG26 (Table A4 in
Appendix).
Overall, the two subjects carried 403 disease-associated variants
with the same genotype (Table S1 in Supplementary Material), but
only 209 of thesewere coding variants, and in only 76 of these posi-
tions the two sequences were homozygous for the risk allele. For
example, both subjects were CC homozygotes for rs222859 (YBX2,
chromosome 17). This gene is associated with male infertility, and
the male subject did not have children (but we have no additional
information). Both subjects were homozygous for the A allele of
rs4880 in SOD2. The alternative allele G is a missense mutation
that changes the amino acid valine to alanine. The common allele
A has been associated with increased oxidative stress that should
act negatively on lifespan, and increased risk for cardiovascular
disease and susceptibility to cancer (Bastaki et al., 2006). How-
ever, there is conﬂicting evidence about the role of this SNP with
some studies that show a protective effect of the A allele in spe-
ciﬁc genetic backgrounds4. Similarly, the two subjects carried the
same heterozygous genotype for SNP rs4641 in LMNA and the
same homozygous genotype GG for SNP rs1801195 in WRN. The
LMNA gene, which encodes the nuclear envelope proteins lamin
A and lamin C, has been associated with the progeroid (premature
aging-like) syndrome, Hutchinson–Gilford syndrome (Eriksson
et al., 2003). Although the T allele of rs4641 was associated with
increased fat mass in elderly twins and increased risk for dia-
betes, the increased fat mass may be associated with decreased
muscle wasting at older ages (Wegner et al., 2010). The WRN
gene is a DNA helicase and exonuclease that plays a role in DNA
repair and another progeroid syndrome,Werner’s Syndrome (Gray
et al., 1997). SNP rs1801195 was associated with decreased risk for
myocardial infarction.
This analysis shows that the two supercentenarians did not
carry a smaller rate of disease-associated variants compared to
other genomes.
Hypothesis 3: the rare variants hypothesis
One of the explanations for the small number of genetic vari-
ants irrefutably linked to exceptional longevity (Schachter et al.,
1994; Barzilai et al., 2003; Christensen et al., 2006) is that rare
or private mutations shared in families may be the major genetic
determinants of this phenotype (Wheeler and Kim, 2011). To test
this hypothesis, we characterized the novel mutations in these
two supercentenarians in terms of functional role and possible
links to age-related diseases. Each subject’s sequence had∼45,000
novel SNPs (Figure 2A), of which 372 and 442 were coding
SNPs in the woman and the man, respectively, and approximately
2% of all novel mutations were coding. This rate is compara-
ble to the overall rate of coding SNPs (Figure A3 in Appendix).
These novel coding mutations are listed in Table S2 in Supple-
mentary Material. We then used the DAVID functional anno-
tation tool5 to determine whether the genes carrying the novel
mutations were enriched in particular functional categories, or
had been associated to categories of age-related diseases. The
woman had 428 genes with novel mutations (including all pos-
sible transcripts) and the man had 500 genes with novel muta-
tions. In both subjects the most signiﬁcantly enriched category
of genes with novel coding mutations was “alternative splicing”
(205 genes in the man and 179 genes in the woman, enrichment
score p-value <5E-04 after Bonferroni correction). In addition,
15 of the genes with novel mutations in the woman were in
the “Immunoglobulin subtype 2” domain (enrichment score p-
value 0.01, after Bonferroni correction). In the man, 22 of the
genes with novel mutations were in the “Cadherin 6/Cell adhe-
sion” domain (enrichment score p-value 0.03 after Bonferroni
correction), and 6 of the genes were in the “von Willebrand
4http://www.snpedia.com/index.php/Rs4880
5http://david.abcc.ncifcrf.gov/
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factor/coagulation” domain (p-value 0.01). The prominence of
novel mutations in genes that direct alternative splicing suggests
the importance of determining the transcriptomes of these two
subjects and other supercentenarians and doing so from spe-
ciﬁc tissue types. This suggests that transcriptional proﬁling by
next generation RNA sequencing (RNA seq) of RNA from cells
obtained or derived from centenarians could be informative in
understanding potentially unique expression patterns in these
individuals.
Eleven of the genes with novel mutations in the woman were
linked to the class of diseases “infection” in the genetic association
database (LTBP2, IL16, SELL, CABIN1, IRF4, KIR2DL3, DDX5,
KIR2DL2, IFNGR2, TLR9, GJB2, p-value 0.066 that however does
not remain signiﬁcant after Bonferroni correction), but no addi-
tional disease categories were found to be signiﬁcantly enriched.
Thirty six genes with novel coding mutations in the man were
linked to the disease classes“infection”and“immune.”These genes
collectively point to the innate immune response and extracellu-
lar matrix remodeling genes collectively arguing for immune and
tissue homeostasis as a nodal point for these subjects.
Figure 5A shows the distribution of genes with novel coding
mutations in the woman (PG17) and the man (PG26) by spe-
ciﬁc diseases. The woman had a higher rate of novel mutations in
genes linked to immune diseases and infections, as well as hema-
tological diseases and development compared to the man. The
man had a higher rate of novel mutations in genes linked to can-
cer, cardiovascular disease, neurological disease, and metabolism.
To test whether the distributions of genes with novel mutations
were signiﬁcantly enriched for these disease categories, we gen-
erated reference distributions for the disease-annotated genes by
randomly selecting genes from the whole list of genes with coding
SNPs in the two subjects. The genes were annotated by disease
groups and average rates and SD were computed in 1,000 resam-
pled sets. The analysis showed that the rate of genes with novel
coding SNPs annotated as “development,” “immune,” “infection,”
and “renal” differed from the distributions expected if the genes
were selected at random in the woman (Figure 5B). Interestingly,
while the rate of genes with novel coding mutations annotated
as “immune” and “infection” in the man was higher than the
mean rate, it was not signiﬁcantly different from what is expected
by chance (Figure 5C). The signiﬁcant enrichment of these dis-
ease categories in the woman but not the man suggests that the
womanmaybe enriched for privatemutations that promote excep-
tional longevity while the man may be enriched for more common
longevity-associated variants. Figure 5D shows some examples of
novel variants.
FIGURE 5 | (A) Rates of genes with novel coding mutations annotated by
disease. Disease groups are as in the labels of (B,C). Note that the woman
did not carry any novel mutations in known aging genes, and neither of
them carried novel coding SNPs in mitochondrial genes. (B)
Resampling-based distributions of the rates of disease-annotated genes in
PG17 when ∼400 genes were selected at random from the list of genes
with coding SNPs. Red asterisks display the rate of disease-annotated
genes with novel coding mutations in PG17. Distributions are based on
1,000 simulations. Error bars represent mean rate±2 SD. (C)
Resampling-based distributions of the rates of disease-annotated genes in
PG26 when∼500 genes were selected at random in the list of genes with
coding SNPs. Distributions are based on 1,000 simulations. (D) A sample
of novel mutations in the female (PG17) and male (PG26). The complete
list is in Table S2 in Supplementary Material.
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Hypothesis 4: the enrichment of longevity variants hypothesis
In a genome-wide association study of exceptional longevity
with 801 centenarians (median age at death 104 years) and 914
genetically matched controls, we identiﬁed 281 SNPs that were
signiﬁcantly associated with exceptional longevity and could be
used to predict the phenotype with 78% sensitivity for a replica-
tion set with a mean age of 108 years (Sebastiani et al., 2012).
Both subjects were included in this analysis and they carried
130 (46%) and 149 (53%) of the SNP alleles that increase the
posterior probability of exceptional longevity. We called these
variants that increase the posterior probability of exceptional
longevity“longevity-associated variants.”Overall, the genetic pro-
ﬁle of the woman translated into a 4.88 posterior odds for excep-
tional longevity, while the genetic proﬁle of the man translated
into an 11.5 posterior odds for exceptional longevity. Since the
majority of SNPs in the genetic model in Sebastiani et al. (2012)
were based on convenience rules used to design commercial SNP
arrays, we investigated whether the longevity-associated variants
in genes were close to coding SNPs in the sequences of the two
subjects that are reported in either dbSNP or HGMD. We iden-
tiﬁed 63 and 68 longevity-associated variants in the woman and
the man (86 was the sum total for the two subjects’ data com-
bined, Table S3 in Supplementary Material) that were in genes.
One of the 86 SNPs was a coding SNP in LY6G6F (HLA-B com-
plex in Chromosome 6) and both subjects were heterozygous at
this position. Seventeen (20%) of the remaining 85 SNPs were
within 10 kb from coding mutations, 33 (39%) were within 50 kb
from coding mutations, and 51 (60%) within 500 kb from cod-
ing mutations (Figure 6A). This analysis suggests that the two
individuals’ sequences are enriched for coding SNPs in proxim-
ity of the longevity-associated variants and Figure 6B shows a
selection of the closest coding mutations. Compared to SNPs ran-
domly selected from the list of SNPs that were studied in the
original genome-wide association study, the longevity-associated
SNPs were much closer to coding SNPs (Figure 6C) and there-
fore this enrichment of coding mutations is not what we would
expect by chance. Similar results were found in Smith et al. (2011).
Based on this analysis, the two sequences appear to be enriched
for coding mutations in close proximity to longevity-associated
variants that were discovered through a genome-wide association
study, and the results reinforce our hypothesis that exceptional
longevity is determinedbymany longevity-associated variants that
may counteract the effect of deleterious or disease-predisposing
variants.
DISCUSSION
We generated the whole genome sequences of a male and a female
supercentenarian who were selected for this study because of both
their exceptional lifespan and healthspan.Although two sequences
do not provide sufﬁcient data for general inference on the genetics
of exceptional longevity, they are a ﬁrst step toward the genera-
tion of a reference panel of exceptionally long-lived individuals
and provide some interesting insights about genetic backgrounds
that might be conducive to exceptional longevity. The $10million
FIGURE 6 | (A) Distance in log 10 (bp) of 51 SNPs that are predictive of
exceptional longevity and nearest non-referent coding SNPs in PG17 and
PG26. (B) Details of the 17 SNPs that are within 10 kb from coding SNPs. (C)
The box plot in red shows the distribution of log 10 (bp) distance between the
longevity-associated variants and the closest coding SNPs in PG17 and PG26.
The 100 box plots in white show the distributions of the distance between
SNPs chosen at random from the SNPs included in the genome-wide
association study in Sebastiani et al. (2012) and the closest coding SNPs in
PG17 and PG26.Wiskhers extend to 1.5 SD from the quartiles and circles
represent outliers.
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Archon Genomics X Prize6 will greatly expand this reference panel
with extremely accurate, 100 “medical grade” and economically
feasible whole genome sequences of centenarians sequenced by
multiple competing teams. It was recently announced that over
1,000 individualswhohave lived to at least age 80without suffering
from any common chronic diseases will have their entire genomes
sequenced and made available to the scientiﬁc community for use
as a reference panel7.
The analysis of next generation sequence data is still very chal-
lenging, and no single mapping and variant calling algorithm has
emerged as the standard tool to use. Therefore, we used two algo-
rithms to select a set of robust variants to examine further. The
speciﬁcally selected data show that the genetic architectures of
the two subjects are comparable to published sequenced genomes,
particularly in terms of rates of coding variants and predicted
damaging variants, and it is likely that overall differences seen
between genomes are due to different platforms, algorithms, and
annotation methods rather than major structural changes that can
be linked to exceptional longevity, at least in the case of germ line
mutations.
We also used the genome sequences of these two subjects to
test different genetic models of exceptional longevity. The insulin
pathway, caloric restriction, and lipid metabolism signiﬁcantly
inﬂuence lifespan in other organisms including the mouse, ﬂy, and
worm (Christensen et al., 2006) and have provided natural candi-
dates for the genetics of human exceptional longevity. Our analysis
shows that while the man had several of the noted longevity vari-
ants in metabolic genes, particularly FOXO3A, the woman was
homozygous only for one variant in HSP70 that is also common
in the population. No additional novel coding SNPs in these puta-
tive genes were discovered, and the different genetic proﬁles of
these candidate genes in the two supercentenarians suggest that
not all of the genetic variants associated with exceptional longevity
to-date are necessary to achieve such survival, and even if some
of these variants may have a role in longevity there are likely
many more yet to be discovered. This suggests that the meta-
bolic hypothesis may be just one of the many paths to exceptional
lifespan.
One of the hypothetical geneticmodels of exceptional longevity
is that, in order for centenarians to achieve their exceptional
survival, they must lack disease-predisposing variants. Phenotyp-
ically, there is evidence that this is not necessarily the case, since
approximately 40% of centenarians have had onset of age-related
diseases before the age of 80 (Evert et al., 2003). On the other
hand, we have observed that supercentenarians tend to escape
both age-related diseases and disability at least beyond the age of
105 years, as in the case of the two subjects in this study (Andersen
et al., 2011). Therefore, we tested whether the genome of these two
subjects had lower rates of disease-associated variants compared
to other published genomes. Surprisingly, both supercentenari-
ans turned out to be carriers of many disease-associated variants,
and the rates of disease-associated variants and protective vari-
ants in the genomes of these two supercentenarians did not differ
6http://genomics.xprize.org/
7http://ir.completegenomics.com/releasedetail.cfm?ReleaseID=610178
from known genomes. These ﬁndings raise several possibilities.
For example, some of the common disease-associated variants
found through genome-wide association studies may have very
little penetrance and this fact would be consistent with their lim-
ited predictive values noted in various studies (Paynter et al., 2010;
Wang et al., 2011). An alternative hypothesis is that centenarians
may carry protective variants that counter the effect of damaging
variants. The enrichment of coding variants nearby SNPs thatwere
found associated with exceptional longevity in our genome-wide
association study (Sebastiani et al., 2012) supports this hypothe-
sis. An interesting ﬁnding from the analysis of disease-annotated
variants is the evidence that several genes may have pleiotropic
effects, and the same gene that can increase risk for disease might
also increase the ability to live long lives. Good examples are the
LMNA andWRN genes, or alleles of SOD2 that were found to have
protective or damaging roles based on the genetic background.
This hypothesis suggests that an analysis that considers individu-
als variants out of their “genetic context” may not be informative
and better methods to analyze the effect of genetic proﬁles are
needed.
An alternative, complementary hypothesis is that variants, pos-
sibly rare, not hitherto associated with health maintenance, com-
pensate for disease-causing variants among the healthy elderly.
In this light, the genomes of these two supercentenarians were
not particularly enriched for novel variants, although the strin-
gency of our approach to variant calling may have increased
the false negative rate to reduce the false-positive rate. Neverthe-
less, the 1% novel variants discovered through this analysis may
lead to the discovery of novel genes involved with exceptional
longevity. The observation that the novel variants were in genes
implicated in “alternative splicing” highlights the importance
of pursuing follow-up studies involving transcriptome sequenc-
ing from different cells and tissues to identify RNA isoforms
or expression proﬁles that may be important for exceptional
longevity.
In summary, the two supercentenarian genomes we studied
have different features including, for example, a number of pri-
vate mutations in speciﬁc categories of genes in the case of the
woman but not the man. Other ongoing studies of centenari-
ans are showing that different centenarian genomes have different
characteristics (Cirulli et al., 2011; Holstege et al., 2011). Rates
of disease-associated variants that are similar to samples of much
younger subjects point to the importance of epigenetic phenom-
ena and the critical presence of longevity-associated variants in
extreme longevity. The enrichment for coding mutations near
longevity-associated variants and the enrichment in novel muta-
tions suggest that a combination of rare and common variants
contribute to the genetic background that allows some individuals
to live beyond the 11th decade.
It is also likely that environmental factors and possibly the
genetic ancestry may inﬂuence the likelihood of an individual to
live long ages directly or by interacting with the genetic back-
ground. The NECS has shown that the chance of male and female
siblings of centenarians to live past 100 can be 8 and 17 times
higher than the risk in the general population (Perls et al., 2002).
Consistent with this observation, our data suggest that the genetic
contribution increases with older and older ages as the limit of
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lifespan is approached (Sebastiani et al., 2012). The male super-
centenarian included in this study had strong longevity in his
family. Although we do not have information about the family his-
tory of the female supercentenarian, she has living offspring who
are approaching their nineties in good health and are currently
enrolled in the NECS. The heterogeneity of the results herein
suggest that sequencing additional exceptionally old individuals
of different genetic ancestry and possibly their family members
will provide the critical information to understand roles of com-
mon and rare genetic determinants of exceptional longevity and
healthspan.
MATERIALS AND METHODS
ETHICS STATEMENT
Subjects provided informed consent and this project was approved
by the Boston University Medical Campus Institutional Review
Board.
SUBJECTS
The man and woman were both age 114+ years at the time of
blood collection for DNA extraction. Their age was conﬁrmed
by birth/baptism certiﬁcates and early U.S. Census entries. For
both subjects we examined the European ancestry by principal
component analysis of genome-wide genotype data, as described
in Sebastiani et al. (2012), and the male had German ancestry,
while the female had a mixed French, Celtic background (see
FigureA10 inAppendix). Theman had been enrolled in theNECS
for 2 years and the woman for 6 years prior to the sequencing
study and their functional and cognitive status were determined
every 1–2 years. Measures of physical (Barthel Index; Mahoney
and Barthel, 1965; Sinoff and Ore, 1997) and cognitive function
(Blessed Information–Memory–Concentration Test; Blessed et al.,
1968; Kawas et al., 1995) were obtained annually. The Barthel
Index measures the ability to independently perform activities
of daily living with a score ranging between 0 and 100. Scores
of 80–100 indicate independent functioning, 60–79 require mini-
mal assistance, 40–59 indicate partial dependence, 20–39 indicate
very dependent, and 0–19 indicate total dependence for perform-
ing activities of daily living. The Blessed Information–Memory–
Concentration Test scores global cognition on a scale 0–37. Scores
of 34 or greater represent no impairment, 27–33 indicate mild
impairment, 21–26 signify moderate impairment, and less than
20 are associated with severe impairment (Kawas et al., 1995). The
man’s Barthel Index andBlessed scores indicated that hewas highly
functional within a year of his death. He had no history of age-
related illnesses except for cataracts (removed at age 74 years) and
an osteoporotic fracture at age 109 years. He had a colon cancer in
his seventies that was surgically removed. His only medication for
years was an aspirin per day. The woman subject was cognitively
intact 6 years prior to the sequencing study and then demonstrated
a steady decline in cognitive and functional status. She was phys-
ically independent up to age 105 years, but then had a decline in
her physical function disproportionate to her decline in cognitive
function, likely due to progressive and severe frailty. She had no
reported age-related illnesses except hypertension and relatively
recently diagnosed dry macular degeneration. She had been on
only two medications, both diuretics, during the last few years of
her life.
SEQUENCING
Peripheral blood was obtained from each subject and used for
DNA extraction. DNA samples were sequenced using a GAII
sequencer at the Illumina Clinical Service Laboratory (San Diego,
CA) using 100 bppaired-end reads. Fastq ﬁleswere generated from
the image ﬁles using the Illumina pipeline software (Firecrest for
image analysis and Bustard for base calling).
MAPPING
Reads in Fastq ﬁles were mapped to the NCBI36 reference genome
including all chromosomes and Mt DNA using the Eland aligner
(Bentley et al., 2008) and BWA (Li and Durbin, 2009; The BWA
version we used was 0.5.9-r16). The Eland_pair alignment algo-
rithm was used to map paired ends with more than 95% genomic
coverage (Figure A11, Table A1 in Appendix). Reads that aligned
to more than one region of the reference genome or that were of
low quality were excluded. The BWA algorithm was used to map
paired end with the options
aln -n 4 -o 1 -e 2 -k 2 -l 35 -R 5
to limit the maximum edit distance to 4, the maximum number
of gap opens to 1, the maximum number of gap extensions to 2,
the maximum number of edit distance in the seed to 2, the seed
to the ﬁrst 35 bases, and to proceed with suboptimal alignment if
there are no more than 5 best hits. The more relaxed thresholds
produced a larger number of aligned reads [1,559,315,652 aligned
reads for PG26 (86.41%) and 1,334,406,235 aligned reads for PG17
(80.85%)].
SNP CALLING
Single nucleotide polymorphisms were called using the CASAVA
algorithm(seehttp://www.illumina.com/software/genomestudio_
software.ilmn and Bentley et al., 2008) and SAMTools (http://
samtools.sourceforge.net/ and Li et al., 2009). PCR duplicates
were removed before running the SNP caller algorithms using
SAMTools. The CASAVA algorithm calls SNPs in two steps, ﬁrst
alleles are called based on base calls, alignment and quality scores,
and then SNPs genotypes are called based on allele calls and read
depths.Alleles scores are approximately equivalent to a Phred score
divided by 10, where the Phred score is −10 log 10 of the poste-
rior probability that the allele call is wrong, and alleles with allele
scores <3 (approximately Phred score <30, and hence error rate
>0.1%) are ﬁltered out. Homozygote genotypes are called at posi-
tions where an allele that differs from the reference genome at that
position has a score >10 and the read depth is <3 (mean depth)
per chromosome. Heterozygote genotypes are called when both
alleles have a score >6 (Phred score >60), and the ratio between
the scores of the two alleles is less than 3. Additional details are
in the supporting manual8. In addition, SAMTools was used to
generate pileup ﬁles from the reads aligned with BWA in the form
of variant calling format ﬁles. SNPs with Phred score <30 were
ﬁltered out.
8http://www.illumina.com/software/genomestudio_software.ilmn
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IDENTIFICATION OF NOVEL VARIANTS
We annotated the single polymorphic bases that differ from the
reference genome (hg18) against dbSNP build 132 and the sum-
mary data distributed by the 1000 Genomes project9 that were
published using coordinates of the UCSC release hg19 of the
human genome. We used the liftover conversion tool in the UCSC
Genome Browser to convert genomic coordinates from hg18 to
hg19, and then calculated the number of polymorphic bases in
the sequences of PG17 and PG26 that are not in dbSNP 132 but
were reported in the December 2010 data release from the 1000
Genomes project. With the exception of 65 positions that map to
22 unique regions in hg18 and could not be remapped to hg19, all
others were successfully translated, andmore than 65%of the vari-
ants not in dbSNP were found in the 1000 Genomes data release.
We also checked novel variants to detect mapping errors and tried
to remove novel variants that were within few bases as those could
be due to mapping errors. After this annotation, approximately
1.5% of the SNPs from the original set that were not found in
dbSNP or 1000 Genomes were labeled as “novel” (Figure 2A).
These steps were conducted with Genephony10, an online tool for
themanipulation of large datasets of genomic information (Nuzzo
and Riva, 2009).
ADDITIONAL GENOMES
We identiﬁed 15 additional whole genome sequences for com-
parison. The samples and references are in Table A2 in
Appendix.
SNP QUALITY
We assessed SNP call quality using several measures.
RUNS OF HOMOZYGOSITY
We used SNP array data genotyped with the Illumina array to
describe the genome-wide structure of chromosomal alterations
of PG17 and PG26. The two samples were genotyped with the
Illumina 610 array (PG17) and 1M array (PG26) and data were
processed as described in Sebastiani et al. (2012). We computed
the B allele frequency (ameasure of heterozygosity/homozygosity)
and the log R ratio (a measure of signal intensity that relates to
copy number variations) using Illumina BeadStudio. The plot of
B allele frequency in Figure A3 in Appendix showed that there
are signiﬁcant stretches of homozygosity across many chromo-
somes (see red arrows). However, this was not associated with
a shift in log R ratio at these locations suggesting that this
was not due to big deletions but probably to inbreeding of her
ancestors with distant relatives that resulted in higher homozy-
gosity. The same analysis for PG26 is displayed in Figure A4 in
Appendix.
CONCORDANCE WITH GENOTYPE CALLS
We compared genotype calls detected from next generation
sequence analysis against the genotype calls determined with SNP
array analysis. Missing genotypes were ignored.
9ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/release/2010_11/
10http://genome.uﬂ.edu/gp/
TRANSITION TO TRANSVERSION RATIOS AND RATE OF
HETEROZYGOSITY
We calculated the number of transitions (A↔G or C↔T) and
transversions (A↔C,T; C↔G; and T↔G) and their rate in all
called SNPs, in SNPs reported only in the 1000 Genomes project,
and in novel SNPs. Rates of heterozygosity were computed by
the ratio of the number of heterozygous calls versus homozygous
calls only for the SNPs with alleles that differ from the reference
genome.
INDEL CALLING
For short indel ﬁnding, the reads were mapped to the human ref-
erence genome (NCBI build 37) using BWA in paired-end mode
with default settings except for the following differences in BWA
aln module: to control false-positive rate, the maximum edit dis-
tance in mapped end (-n) was lowered from 5 (default for 100 bp
reads) to 4, and, to increase pairing accuracy, the seed size (-l) was
decreased to 20 and the number of best hits to search in subopti-
mal alignments (-R) was increased to 100. In BWA sampe module,
the number of occurrences for one end (-o) was increased to 10
million.
We found that usingBWAwith the last three parameters reduces
the number of discordant pairs and pairs with ends mapped
to different chromosomes without sacriﬁcing overall alignment
accuracy. Since Dindel uses both ends of discordant pairs for
realignment and for calculation of variant qualities, we wanted
to keep the number of discordant pairs low. The BAM alignment
ﬁles produced by BWA were merged and split by chromosomes,
library and read group information was added, and duplicates
were removed on per-library basis using Picard MarkDuplicates.
Short indel calls were made using Dindel and SAMTools mpileup.
Since our data were relatively high coverage, before running Din-
del, candidate indels were selected with – minCount parameter set
to 3 using the script in the Dindel package. SAMTools mpileup was
run with mapping quality coefﬁcient –C50. For the mitochondrial
chromosomes where coverage exceeded 3,000 due to high sample
copy number, we increased maximum depth in mpileup to one
million. Only indels that were called by both algorithms and had
a Phred score>30 were selected for further annotation.
FUNCTIONAL ANNOTATION
For bioinformatics analysis, we used the complementary genome-
wide variant annotation tools embedded in a suite of tools devel-
oped by researchers at The Scripps Research Institute (Torka-
mani et al., 2011) as well as Genephony (Nuzzo and Riva, 2009).
These tools integrate different approaches to assessing the likely
functional signiﬁcance of DNA sequence variants based on infor-
mation such as genomic region, functional elements they reside
in, conservation of nucleotides, biophysical properties of the
nucleotide or amino acid sequence they reside in, known role
in gene/protein function, disease associations. These annotations
provide insights that link speciﬁc variants to gene function by
predicting whether or not the variant impacts, e.g., a transcrip-
tion factor binding site, or a microRNA binding site, a splice site,
and/or whether they impact the function of a proteins. These
tools both incorporate and go well beyond other available tools
for variant functional prediction such as SIFT and POLYPHEN
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by considering more information as well as regulatory genomic
elements.
LIST OF DISEASE-ANNOTATED VARIANTS
We compiled this list by merging disease-annotated variants
from the HGMD11 with the catalog of genome-wide association
studies12. We completed the list of variants in the GWAS catalog
by searching for the unreported SNP alleles, and then compared
the full sequences of PG17 and PG26 to detect the SNPs with risk
alleles. Note that for this analysis we used the assembled sequences
and not only the SNPs that were called by the SNP caller algo-
rithms, because several of the risk alleles are actually the reference
allele in the hg18 version of the human genome. All SNPs in the
catalog were recoded according to the forward strand to make the
results comparable to the whole genome sequences. We analyzed
the number of risk alleles stratiﬁed by whether they belong to a
coding SNP. Protective variants were identiﬁed by searching for
the key-words “reduced risk” in disease annotation.
ENRICHMENT ANALYSIS
We used the David functional tool (Huang da et al., 2009) to anno-
tate genes by functional role and association with diseases. The
disease associations are based on the genetic association database
and disease classes derived in Zhang et al. (2010). To test whether
the distributions of genes with novel mutations in PG17 and PG26
were signiﬁcantly enriched for the found disease categories, we
generated reference distributions as follows.We randomly selected
421 genes from the whole list of genes with coding SNPs in PG17
and 500 genes from the whole list of genes with coding SNPs in
PG26, and the genes lists were annotated by disease groups. We
repeated the random selection 1,000 times and then computed
average rates and SD.
11http://www.hgmd.org/
12http://www.genome.gov/gwastudies/
LONGEVITY-ASSOCIATED VARIANTS
We detected the longevity-associated variants in PG17 and PG26
as those genotypes that increase the posterior probability of excep-
tional longevity in the two subjects in the list of 281 SNPs reported
in Sebastiani et al. (2012). We selected the longevity-associated
variants that were in genes, searched the closest coding mutation
called by the SNPs callers or the closets coding mutations in the
HGMD for each longevity variants and then computed the physi-
cal distances. Genes that did not have any coding mutation in the
sequences were ignored. To build reference distributions, we ran-
domly selected 281 SNPs from the list of SNPs that were included
in the genome-wide association study of exceptional longevity as
described in Sebastiani et al. (2012), selected the SNPs located in
genes and searched for the closest coding mutation in the same
genes that were called by the SNP callers or were in the HGMD.
The box plot in Figure 6C shows 100 replications of random
selection.
ACKNOWLEDGMENTS
This work was funded by grants from the National Institute on
Aging R56-AG027216 (Clinton T. Baldwin), R01HL087681 (Mar-
tin H. Steinberg), K24AG025727 and a Glenn Foundation for
Medical Research Breakthroughs in Gerontology Award (Thomas
T. Perls), National Science Foundation IIS-1017621 (Gary Ben-
son), NIH/NCRR UL1 RR025774; NIH/NHLBI R01 HL089655-
03; and NIH/NIDA R01 DA030976, and the Price Founda-
tion and Scripps Genomic Medicine (Ali Torkamani, Nicholas
J. Schork, Phillip Pham). We are beholden to the very spe-
cial and wonderful subjects of this study for their interest and
participation.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at http://www.frontiersin.org/genetics_of_aging/10.3389/fgene.
2011.00090/abstract
REFERENCES
Albers, C. A., Lunter, G., MacArthur, D.
G., McVean, G., Ouwehand, W. H.,
andDurbin,R. (2011). Dindel: accu-
rate indel calls from short-read data.
Genome Res. 21, 961–973.
Al-Regaiey, K. A., Masternak, M.
M., Bonkowski, M., Sun, L., and
Bartke,A. (2005). Long-lived growth
hormone receptor knockout mice:
interaction of reduced insulin-like
growth factor i/insulin signaling
and caloric restriction. Endocrinol-
ogy 146, 851–860.
Andersen, S., Sebastiani, P., Dworkis,
D. A., Feldman, L., and Perls, T. T.
(2011). Health span approximates
life span amongst many supercente-
narians. J. Gerontol. A Biol. Sci. Med.
Sci. doi: 10.1093/gerona/glr223.
[Epub ahead of print].
Arai, Y., Takayama, M., Gondo,
Y., Inagaki, H., Yamamura, K.,
Nakazawa, S., Kojima, T., Ebihara,
Y., Shimizu, K., Masui, Y., Kitagawa,
K., Takebayashi, T., and Hirose, N.
(2008). Adipose endocrine function,
insulin-like growth factor-1 axis,
and exceptional survival beyond 100
years of age. J. Gerontol. A Biol. Sci.
Med. Sci. 63, 1209–1218.
Arking, D. E., Krebsova, A., Macek, M.
Sr., Macek, M. Jr., Arking, A., Mian,
I. S., Fried, L., Hamosh, A., Dey, S.,
McIntosh, I., andDietz,H.C. (2002).
Association of human aging with a
functional variant of klotho. Proc.
Natl. Acad. Sci. U.S.A. 99, 856–861.
Atzmon, G., Rincon, M., Rabizadeh, P.,
and Barzilai, N. (2005). Biological
evidence for inheritance of excep-
tional longevity. Mech. Ageing Dev.
126, 341–345.
Barzilai, N., Atzmon, G., Derby, C. A.,
Bauman, J. M., and Lipton, R. B.
(2006). A genotype of exceptional
longevity is associated with preser-
vation of cognitive function. Neurol-
ogy 67, 2170–2175.
Barzilai, N., Atzmon, G., Schechter, C.,
Schaefer, E. J., Cupples,A. L., Lipton,
R., Cheng, S., and Shuldiner, A. R.
(2003). Unique lipoprotein pheno-
type and genotype associated with
exceptional longevity. JAMA 290,
2030–2040.
Bastaki, M., Huen, K., Manzanillo,
P., Chande, N., Chen, C., Balmes,
J. R., Tager, I. B., and Holland,
N. (2006). Genotype-activity rela-
tionship for Mn-superoxide dismu-
tase, glutathione peroxidase 1 and
catalase in humans. Pharmacogenet.
Genomics 16, 279–286.
Bentley, D. R., Balasubramanian, S.,
Swerdlow,H. P., Smith,G. P.,Milton,
J., Brown, C. G., Hall, K. P., Evers,
D. J., Barnes, C. L., Bignell, H. R.,
Boutell, J. M., Bryant, J., Carter, R. J.,
Keira Cheetham, R., Cox, A. J., Ellis,
D. J., Flatbush, M. R., Gormley, N.
A., Humphray, S. J., Irving, L. J., Kar-
belashvili, M. S., Kirk, S. M., Li, H.,
Liu,X.,Maisinger,K. S.,Murray,L. J.,
Obradovic, B.,Ost, T., Parkinson,M.
L., Pratt, M. R., Rasolonjatovo, I. M.,
Reed, M. T., Rigatti, R., Rodighiero,
C., Ross, M. T., Sabot, A., Sankar, S.
V., Scally, A., Schroth, G. P., Smith,
M. E., Smith, V. P., Spiridou, A., Tor-
rance, P. E., Tzonev, S. S., Vermaas,
E. H., Walter, K., Wu, X., Zhang, L.,
Alam, M. D., Anastasi, C., Aniebo,
I. C., Bailey, D. M., Bancarz, I. R.,
Banerjee, S., Barbour, S. G., Bay-
bayan, P. A., Benoit, V. A., Benson,
K. F., Bevis, C., Black, P. J., Bood-
hun, A., Brennan, J. S., Bridgham, J.
A., Brown, R. C., Brown,A. A., Buer-
mann, D. H., Bundu,A. A., Burrows,
J. C.,Carter,N. P.,Castillo,N.,Chiara
E. Catenazzi, M., Chang, S., Neil
Cooley, R., Crake,N. R., Dada,O. O.,
Diakoumakos, K. D., Dominguez-
Fernandez, B., Earnshaw,D. J., Egbu-
jor, U. C., Elmore, D. W., Etchin,
S. S., Ewan, M. R., Fedurco, M.,
Fraser, L. J., Fuentes Fajardo, K. V.,
Scott Furey, W., George, D., Giet-
zen, K. J., Goddard, C. P., Golda,
G. S., Granieri, P. A., Green, D.
E., Gustafson, D. L., Hansen, N. F.,
Harnish, K., Haudenschild, C. D.,
Heyer, N. I., Hims, M. M., Ho, J. T.,
www.frontiersin.org January 2012 | Volume 2 | Article 90 | 13
Sebastiani et al. Whole genome sequences of supercentenarians
Horgan, A. M., Hoschler, K., Hur-
witz, S., Ivanov, D. V., Johnson, M.
Q., James, T.,Huw Jones, T. A., Kang,
G. D., Kerelska, T. H., Kersey, A.
D., Khrebtukova, I., Kindwall, A. P.,
Kingsbury, Z., Kokko-Gonzales, P. I.,
Kumar,A., Laurent,M.A., Lawley,C.
T.,Lee,S. E.,Lee,X.,Liao,A.K.,Loch,
J. A., Lok, M., Luo, S., Mammen, R.
M., Martin, J. W., McCauley, P. G.,
McNitt, P., Mehta, P., Moon, K. W.,
Mullens, J. W., Newington, T., Ning,
Z., Ling Ng, B., Novo, S. M., O’Neill,
M. J., Osborne, M. A., Osnowski, A.,
Ostadan, O., Paraschos, L. L., Pick-
ering, L., Pike, A. C., Pike, A. C.,
Chris Pinkard,D., Pliskin,D. P., Pod-
hasky, J., Quijano, V. J., Raczy, C.,
Rae, V. H., Rawlings, S. R., Chiva
Rodriguez, A., Roe, P. M., Rogers, J.,
Rogert Bacigalupo,M. C., Romanov,
N., Romieu, A., Roth, R. K., Rourke,
N. J., Ruediger, S. T., Rusman, E.,
Sanches-Kuiper, R. M., Schenker, M.
R., Seoane, J. M., Shaw, R. J., Shiver,
M. K., Short, S.W., Sizto,N. L., Sluis,
J. P., Smith, M. A., Ernest Sohna
Sohna, J., Spence, E. J., Stevens, K.,
Sutton, N., Szajkowski, L., Tregidgo,
C. L., Turcatti, G., Vandevondele, S.,
Verhovsky, Y., Virk, S. M., Wakelin,
S., Walcott, G. C., Wang, J., Wors-
ley, G. J., Yan, J., Yau, L., Zuerlein,
M., Rogers, J.,Mullikin, J. C., Hurles,
M. E., McCooke, N. J., West, J. S.,
Oaks, F. L., Lundberg, P. L., Klen-
erman, D., Durbin, R., and Smith,
A. J. (2008). Accurate whole human
genome sequencing using reversible
terminator chemistry. Nature 456,
53–59.
Blessed, G., Tomlinson, B. E., and Roth,
M. (1968). The association between
quantitative measures of dementia
and of senile change in the cerebral
grey matter of elderly subjects. Br. J.
Psychiatry 114, 797–811.
Bloss,C. S.,Pawlikowska,L., andSchork,
N. J. (2010). Contemporary human
genetic strategies in aging research.
Ageing Res. Rev. 10, 191–200.
Bonafe, M., Barbieri, M., Marchegiani,
F., Olivieri, F., Ragno, E., Giampieri,
C., Mugianesi, E., Centurelli, M.,
Franceschi, C., and Paolisso, G.
(2003). Polymorphic variants of
insulin-like growth factor I (IGF-
I) receptor and phosphoinositide 3-
kinase genes affect IGF-I plasma
levels and human longevity: cues
for an evolutionarily conserved
mechanism of life span control.
J. Clin. Endocrinol. Metab. 88,
3299–3304.
Christensen, K., Johnson, T. E., and
Vaupel, J. W. (2006). The quest
for genetic determinants of human
longevity: challenges and insights.
Nat. Rev. Genet. 7, 436–448.
Chua, K. F., Mostoslavsky, R., Lom-
bard, D. B., Pang, W. W., Saito, S.,
Franco, S., Kaushal, D., Cheng, H.
L., Fischer, M. R., Stokes, N., Mur-
phy, M. M., Appella, E., and Alt, F.
W. (2005). Mammalian SIRT1 lim-
its replicative life span in response to
chronic genotoxic stress. Cell Metab.
2, 67–76.
Cirulli, E. T.,Zhu,M., Shianna,K.V.,Ge,
D., and Goldstein, D. B. (2011). Next
Generation Sequencing of Centenar-
ian and Control Genomes. Montreal:
ACHG.
Drmanac, R., Sparks, A. B., Callow, M.
J., Halpern, A. L., Burns, N. L., Ker-
mani,B.G.,Carnevali,P.,Nazarenko,
I., Nilsen, G. B., Yeung, G., Dahl, F.,
Fernandez, A., Staker, B., Pant, K.
P., Baccash, J., Borcherding, A. P.,
Brownley, A., Cedeno, R., Chen, L.,
Chernikoff, D., Cheung, A., Chirita,
R.,Curson,B., Ebert, J. C.,Hacker,C.
R., Hartlage, R., Hauser, B., Huang,
S., Jiang, Y., Karpinchyk, V., Koenig,
M., Kong, C., Landers, T., Le, C., Liu,
J., McBride, C. E., Morenzoni, M.,
Morey, R. E., Mutch, K., Perazich,
H., Perry, K., Peters, B. A., Peter-
son, J., Pethiyagoda, C. L., Pothu-
raju, K., Richter, C., Rosenbaum,
A. M., Roy, S., Shafto, J., Sharan-
hovich, U., Shannon, K. W., Sheppy,
C. G., Sun, M., Thakuria, J. V., Tran,
A., Vu, D., Zaranek, A. W., Wu, X.,
Drmanac, S.,Oliphant,A. R., Banyai,
W. C., Martin, B., Ballinger, D. G.,
Church, G. M., and Reid, C. A.
(2009). Human genome sequencing
using unchained base reads on self-
assembling DNA nanoarrays. Sci-
ence 327, 78–81.
Ebersberger, I., Metzler, D., Schwarz, C.,
and Paabo, S. (2002). Genomewide
comparison of DNA sequences
between humans and chimpanzees.
Am. J. Hum. Genet. 70, 1490–1497.
Eriksson, M., Brown, W. T., Gordon, L.
B., Glynn, M. W., Singer, J., Scott,
L., Erdos, M. R., Robbins, C. M.,
Moses, T. Y., Berglund, P., Dutra,
A., Pak, E., Durkin, S., Csoka, A.
B., Boehnke, M., Glover, T. W., and
Collins, F. S. (2003). Recurrent de
novo point mutations in lamin A
cause Hutchinson-Gilford progeria
syndrome. Nature 423, 293–298.
Evert, J., Lawler, E., Bogan,H., and Perls,
T. (2003). Morbidity proﬁles of cen-
tenarians: survivors, delayers, and
escapers. J. Gerontol. A Biol. Sci.Med.
Sci. 58, 232–237.
Fraser, G. E., and Shavlik, D. J. (2001).
Ten years of life: is it a matter
of choice? Arch. Intern. Med. 161,
1645–1652.
Gatta, L. B., Vitali, M., Zanola, A.,
Venturelli, E., Fenoglio, C., Galim-
berti, D., Scarpini, E., and Finazzi,
D. (2008). Polymorphisms in the
LOC387715/ARMS2 putative gene
and the risk for Alzheimer’s disease.
Dement. Geriatr. Cogn. Disord. 26,
169–174.
Gray, M. D., Shen, J. C., Kamath-Loeb,
A. S., Blank, A., Sopher, B. L., Mar-
tin,G.M.,Oshima, J., and Loeb, L.A.
(1997). The Werner syndrome pro-
tein is a DNA helicase. Nat. Genet.
17, 100–103.
Guarente, L., and Kenyon, C. (2000).
Genetic pathways that regulate age-
ing in model organisms. Nature 408,
255–262.
Herskind, A. M., McGue, M., Holm, N.
V., Sorensen, T. I., Harvald, B., and
Vaupel, J. W. (1996). The heritability
of human longevity: a population-
based study of 2872 Danish twin
pairs born 1870-1900. Hum. Genet.
97, 319–323.
Hindorff, L. A., Junkins, H. A., Mehta,
J. P., and Manolio, T. A. (2011). A
Catalog of Published Genome-Wide
Association Studies. Available at:
http://www.genome.gov/gwastudies/
[accessed April 30, 2011].
Holstege, H., Sie, D., Harkins, T., Lee,
C., Ross, T., McLaughlin, S., Shah,
M., Ylstra, B., Meijer, G., Meijers-
Heijboer,H.,Heutink, P., Shaw Mur-
ray, S., Reinders, M., Holstege, G.,
Sistermans, E., and Levy, S. (2011).A
Longevity Reference Genome Gener-
ated From theWorld’s OldestWoman.
Montreal: ACHG.
Holzenberger, M., Dupont, J., Ducos,
B., Leneuve, P., Geloen, A., Even,
P. C., Cervera, P., and Le Bouc,
Y. (2003). IGF-1 receptor regulates
lifespan and resistance to oxidative
stress in mice. Nature 421, 182–187.
Huang da, W., Sherman, B. T., and
Lempicki, R. A. (2009). Systematic
and integrative analysis of large gene
lists using DAVID bioinformatics
resources. Nat. Protoc. 4, 44–57.
Kawas, C., Karagiozis, H., Resau, L.,
Corrada, M., and Brookmeyer, R.
(1995). Reliability of the blessed
telephone information-memory-
concentration test. J. Geriatr.
Psychiatry Neurol. 8, 238–242.
Kim, J. I., Ju, Y. S., Park, H., Kim, S.,
Lee, S., Yi, J. H., Mudge, J., Miller,
N. A., Hong, D., Bell, C. J., Kim, H.
S., Chung, I. S., Lee, W. C., Lee, J.
S., Seo, S. H., Yun, J. Y., Woo, H.
N., Lee, H., Suh, D., Lee, S., Kim, H.
J., Yavartanoo, M., Kwak, M., Zheng,
Y., Lee, M. K., Park, H., Kim, J. Y.,
Gokcumen,O.,Mills, R. E., Zaranek,
A. W., Thakuria, J., Wu, X., Kim, R.
W., Huntley, J. J., Luo, S., Schroth,
G. P., Wu, T. D., Kim, H., Yang, K.
S., Park, W. Y., Kim, H., Church, G.
M., Lee, C., Kingsmore, S. F., and
Seo, J. S. (2009). A highly annotated
whole-genome sequence of a Korean
individual. Nature 460, 1011–1015.
Kojima, T., Kamei, H., Aizu, T., Arai,
Y., Takayama, M., Nakazawa, S.,
Ebihara, Y., Inagaki, H., Masui, Y.,
Gondo, Y., Sakaki, Y., and Hirose, N.
(2004). Association analysis between
longevity in the Japanese population
and polymorphic variants of genes
involved in insulin and insulin-like
growth factor 1 signaling pathways.
Exp. Gerontol. 39, 1595–1598.
Kops, G. J., Dansen, T. B., Polderman,
P. E., Saarloos, I., Wirtz, K. W., Cof-
fer, P. J., Huang, T. T., Bos, J. L.,
Medema,R.H., andBurgering,B.M.
(2002). Forkhead transcription fac-
tor FOXO3a protects quiescent cells
from oxidative stress. Nature 419,
316–321.
Kuningas, M., Putters, M., Westendorp,
R. G., Slagboom, P. E., and van
Heemst, D. (2007). SIRT1 gene, age-
related diseases, and mortality: the
Leiden 85-plus study. J. Gerontol. A
Biol. Sci. Med. Sci. 62, 960–965.
Kuro-o, M., Matsumura, Y., Aizawa,
H., Kawaguchi, H., Suga, T., Utsugi,
T., Ohyama, Y., Kurabayashi, M.,
Kaname, T., Kume, E., Iwasaki, H.,
Iida, A., Shiraki-Iida, T., Nishikawa,
S., Nagai, R., and Nabeshima, Y.
I. (1997). Mutation of the mouse
klotho gene leads to a syndrome
resembling ageing. Nature 390,
45–51.
Kurosu, H., Yamamoto, M., Clark, J.
D., Pastor, J. V., Nandi, A., Gur-
nani, P.,McGuinness,O. P.,Chikuda,
H., Yamaguchi, M., Kawaguchi, H.,
Shimomura, I., Takayama, Y., Herz,
J., Kahn, C. R., Rosenblatt, K. P.,
and Kuro-o, M. (2005). Suppression
of aging in mice by the hormone
Klotho. Science 309, 1829–1833.
Lee, S. S., Kennedy, S., Tolonen, A. C.,
and Ruvkun, G. (2003). DAF-16 tar-
get genes that control C. elegans life-
span and metabolism. Science 300,
644–647.
Levy, S., Sutton, G., Ng, P. C., Feuk, L.,
Halpern, A. L., Walenz, B. P., Axel-
rod, N., Huang, J., Kirkness, E. F.,
Denisov, G., Lin, Y., MacDonald, J.
R., Pang, A. W., Shago, M., Stock-
well, T. B., Tsiamouri, A., Bafna, V.,
Bansal, V., Kravitz, S. A., Busam, D.
A., Beeson, K. Y., McIntosh, T. C.,
Remington, K. A., Abril, J. F., Gill,
J., Borman, J., Rogers, Y. H., Fra-
zier,M. E., Scherer, S.W., Strausberg,
R. L., and Venter, J. C. (2007). The
diploid genome sequence of an indi-
vidual human. PLoS Biol. 5, e254.
doi: 10.1371/journal.pbio.0050254.
Li, H., and Durbin, R. (2009). Fast and
accurate short read alignment with
Burrows-Wheeler transform. Bioin-
formatics 25, 1754–1760.
Frontiers in Genetics | Genetics of Aging January 2012 | Volume 2 | Article 90 | 14
Sebastiani et al. Whole genome sequences of supercentenarians
Li, H., Handsaker, B., Wysoker, A., Fen-
nell, T., Ruan, J., Homer, N., Marth,
G., Abecasis, G., Durbin, R., and
1000 Genome Project Data Process-
ing Subgroup. (2009). The Sequence
Alignment/Map format and SAM-
tools. Bioinformatics 25, 2078–2079.
Lohmueller,K. E., Indap,A. R., Schmidt,
S., Boyko, A. R., Hernandez, R. D.,
Hubisz, M. J., Sninsky, J. J., White,
T. J., Sunyaev, S. R., Nielsen, R.,
Clark, A. G., and Bustamante, C. D.
(2008). Proportionally more delete-
rious genetic variation in European
than in African populations. Nature
451, 994–997.
Mahoney, F. I., and Barthel, D. W.
(1965). Functional evaluation: the
Barthel Index. Md. State Med. J. 14,
61–65.
Metzker,M. L. (2009). Sequencing tech-
nologies – the next generation. Nat.
Rev. Genet. 11, 31–46.
Moore, B., Hu, H., Singleton, M., Reese,
M. G., De La Vega, F. M., and Yan-
dell, M. (2011). Global analysis of
disease-relatedDNA sequence varia-
tion in 10 healthy individuals: impli-
cations for whole genome-based
clinical diagnostics. Genet. Med. 13,
210–217.
Nalls, M. A., Simon-Sanchez, J., Gibbs,
J. R., Paisan-Ruiz, C., Bras, J. T.,
Tanaka, T., Matarin, M., Scholz, S.,
Weitz, C., Harris, T. B., Ferrucci,
L., Hardy, J., and Singleton, A. B.
(2009). Measures of autozygosity
in decline: globalization, urbaniza-
tion, and its implications formedical
genetics. PLoS Genet. 5, e1000415.
doi:10.1371/journal.pgen.1000415.
Nuzzo, A., and Riva, A. (2009).
Genephony: a knowledge manage-
ment tool for genome-wide research.
BMC Bioinformatics 10, 278. doi:
10.1186/1471-2105-10-278
Paynter, N. P., Chasman, D. I., Pare, G.,
Buring, J. E., Cook,N. R.,Miletich, J.
P., and Ridker, P. M. (2010). Asso-
ciation between a literature-based
genetic risk score and cardiovascu-
lar events in women. JAMA 303,
631–637.
Pawlikowska, L., Hu, D., Huntsman, S.,
Sung, A., Chu, C., Chen, J., Joyner,
A. H., Schork, N. J., Hsueh, W.
C., Reiner, A. P., Psaty, B. M., Atz-
mon, G., Barzilai, N., Cummings,
S. R., Browner, W. S., Kwok, P.
Y., Ziv, E., and Study of Osteo-
porotic Fractures. (2009). Associa-
tion of common genetic variation in
the insulin/IGF1 signaling pathway
with human longevity. Aging Cell 8,
460–472.
Perls, T., Shea-Drinkwater, M., Bowen-
Flynn, J., Ridge, S. B., Kang, S.,
Joyce, E., Daly, M., Brewster, S. J.,
Kunkel, L., and Puca, A. A. (2000).
Exceptional familial clustering for
extreme longevity in humans. J. Am.
Geriatr. Soc. 48, 1483–1485.
Perls, T. T., Wilmoth, J., Levenson, R.,
Drinkwater, M., Cohen, M., Bogan,
H., Joyce, E., Brewster, S., Kunkel, L.,
and Puca, A. (2002). Life-long sus-
tained mortality advantage of sib-
lings of centenarians. Proc. Natl.
Acad. Sci. U.S.A. 99, 8442–8447.
Schachter, F., Faure-Delanef, L.,Guenot,
F., Rouger, H., Froguel, P., Lesueur-
Ginot, L., and Cohen, D. (1994).
Genetic associations with human
longevity at the APOE and ACE loci.
Nat. Genet. 6, 29–32.
Schoenmaker, M., de Craen, A. J., de
Meijer,P.H.,Beekman,M.,Blauw,G.
J., Slagboom, P. E., and Westendorp,
R. G. (2006). Evidence of genetic
enrichment for exceptional survival
using a family approach: the Leiden
Longevity Study. Eur. J. Hum. Genet.
14, 79–84.
Sebastiani, P., Solovieff, N., DeWan, A.,
Walsh, K., Puca, A., Hartley, S. W.,
Melista, E.,Andersen, S.,Dworkis,D.
A., Wilk, J. B., Myers, R. H., Stein-
berg, M. H., Montano, M., Baldwin,
C. T., Hoh, J., and Perls, T. T. (2012).
Genetic signatures of exceptional
longevity in humans. PLoS ONE.
doi: 10.1371/journal.pone.0029848
Sinoff, G., and Ore, L. (1997). The
Barthel activities of daily living
index: self-reporting versus actual
performance in the old-old (> or
= 75 years). J. Am. Geriatr. Soc. 45,
832–836.
Smith, E. N., Koller, D. L., Panganiban,
C., Szelinger, S., Zhang, P., Badner,
J. A., Barrett, T. B., Berrettini, W.
H., Bloss, C. S., Byerley, W., Coryell,
W., Edenberg, H. J., Foroud, T., Ger-
shon,E. S.,Greenwood,T.A.,Guo,Y.,
Hipolito, M., Keating, B. J., Lawson,
W. B., Liu, C., Mahon, P. B., McIn-
nis, M. G., McMahon, F. J., McKin-
ney, R., Murray, S. S., Nievergelt, C.
M., Nurnberger, J. I. Jr., Nwulia, E.
A., Potash, J. B., Rice, J., Schulze, T.
G., Scheftner, W. A., Shilling, P. D.,
Zandi, P. P., Zöllner, S., Craig, D. W.,
Schork,N. J., andKelsoe, J. R. (2011).
Genome-wide association of bipo-
lar disorder suggests an enrichment
of replicable associations in regions
near genes. PLoS Genet. 7, e1002134.
doi:10.1371/journal.pgen.1002134
Solovieff, N., Hartley, S. W., Baldwin,
C. T., Perls, T. T., Steinberg, M. H.,
and Sebastiani, P. (2010). Clustering
by genetic ancestry using genome-
wide data. BMC Genet. 11, 108.
doi:10.1186/1471-2156-11-108
Song, F., Ji, P., Zheng, H.,Wang, Y., Hao,
X., Wei, Q., Zhang, W., and Chen,
K. (2010). Deﬁnition of a functional
single nucleotide polymorphism in
the cell migration inhibitory gene
MIIP that affects the risk of breast
cancer. Cancer Res. 70, 1024–1032.
Stenson, P. D., Mort, M., Ball, E. V.,
Howells, K., Phillips, A. D., Thomas,
N. S., and Cooper, D. N. (2009).
The Human Gene Mutation Data-
base: 2008 update. Genome Med. 1,
13.
Suh,Y.,Atzmon,G., Cho,M. O.,Hwang,
D., Liu, B., Leahy, D. J., Barzilai, N.,
and Cohen, P. (2008). Functionally
signiﬁcant insulin-like growth factor
I receptor mutations in centenari-
ans. Proc. Natl. Acad. Sci. U.S.A. 105,
3438–3442.
Tan, Q., Zhao, J. H., Zhang, D., Kruse,
T. A., and Christensen, K. (2008).
Power for genetic association study
of human longevity using the case-
control design. Am. J. Epidemiol.
168, 890–896.
Terry, D. F., Sebastiani, P., Andersen, S.
L., and Perls, T. T. (2008). Disentan-
gling the roles of disability and mor-
bidity in survival to exceptional old
age.Arch. Intern. Med. 168, 277–283.
The 1000 Genomes Project Consor-
tium. (2010). A map of human
genome variation from population-
scale sequencing. Nature 467,
1061–1073.
Torkamani, A., Scott-Van Zeeland,
A. A., Topol, E. J., and Schork,
N. J. (2011). Annotating individ-
ual human genomes. Genomics 98,
233–241.
Vaziri, H., Dessain, S., Eaton, E. N.,
Imaii, S. I., Frye, A. R., Pandita, T.
K., Guarente, L., and Weinberg, R.
A. (2001). hSir2 (SirT1) functions as
an NAD-dependent p53 deacetylase.
Cell 107, 149–159.
Wang, J.,Wang,W., Li, R., Li,Y., Tian,G.,
Goodman, L., Fan, W., Zhang, J., Li,
J., Zhang, J., Guo, Y., Feng, B., Li, H.,
Lu, Y., Fang, X., Liang, H., Du, Z., Li,
D., Zhao, Y., Hu, Y., Yang, Z., Zheng,
H., Hellmann, I., Inouye, M., Pool,
J., Yi, X., Zhao, J., Duan, J., Zhou, Y.,
Qin, J.,Ma,L., Li,G.,Yang,Z.,Zhang,
G., Yang, B., Yu, C., Liang, F., Li, W.,
Li, S., Li, D., Ni, P., Ruan, J., Li, Q.,
Zhu, H., Liu, D., Lu, Z., Li, N., Guo,
G., Zhang, J., Ye, J., Fang, L., Hao,
Q., Chen, Q., Liang, Y., Su, Y., San,
A., Ping, C., Yang, S., Chen, F., Li, L.,
Zhou, K., Zheng, H., Ren, Y., Yang,
L., Gao, Y., Yang, G., Li, Z., Feng, X.,
Kristiansen,K.,Wong,G.K.,Nielsen,
R.,Durbin,R., Bolund, L., Zhang,X.,
Li, S., Yang, H., and Wang, J. (2008).
The diploid genome sequence of an
Asian individual. Nature 456, 60–65.
Wang, J. H., Pappas, D., De Jager, P.
L., Pelletier, D., de Bakker, P. I.,
Kappos, L., Polman, C. H., Aus-
tralian and New Zealand Multi-
ple Sclerosis Genetics Consortium
(ANZgene), Chibnik, L. B., Haﬂer,
D. A., Matthews, P. M., Hauser, S.
L., Baranzini, S. E., and Oksenberg,
J. R. (2011). Modeling the cumula-
tive genetic risk formultiple sclerosis
from genome-wide association data.
Genome Med. 3, 3.
Wegner, L., Anthonsen, S., Bork-Jensen,
J.,Dalgaard, L.,Hansen,T., Pedersen,
O., Poulsen, P., and Vaag, A. (2010).
LMNA rs4641 and the muscle lamin
A and C isoforms in twins – meta-
bolic implications and transcrip-
tional regulation. J. Clin. Endocrinol.
Metab. 95, 3884–3892.
Wheeler, H. E., and Kim, S. K. (2011).
Genetics and genomics of human
ageing. Philos. Trans. R. Soc. Lond.
B Biol. Sci. 366, 43–50.
Willcox, B. J., Donlon, T. A., He,
Q., Chen, R., Grove, J. S., Yano,
K., Masaki, K. H., Willcox, D.
C., Rodriguez, B., and Curb, J.
D. (2008). FOXO3A genotype is
strongly associated with human
longevity. Proc. Natl. Acad. Sci.
U.S.A. 105, 13987–13992.
Zhang, Y., De, S., Garner, J. R., Smith,
K., Wang, S. A., and Becker, K. G.
(2010). Systematic analysis, com-
parison, and integration of disease
based human genetic association
data and mouse genetic phenotypic
information.BMCMed. Genomics 3,
1. doi:10.1186/1755-8794-3-1
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 20 October 2011; accepted: 04
December 2011; published online: 03 Jan-
uary 2012.
Citation: Sebastiani P, Riva A, Mon-
tano M, Pham P, Torkamani A, Scherba
E, Benson G, Milton JN, Baldwin
CT, Andersen S, Schork NJ, Stein-
berg MH and Perls TT (2012) Whole
genome sequences of a male and
female supercentenarian, ages greater
than 114 years. Front. Gene. 2:90. doi:
10.3389/fgene.2011.00090
This article was submitted to Frontiers in
Genetics of Aging, a specialty of Frontiers
in Genetics.
Copyright© 2012 Sebastiani, Riva,Mon-
tano, Pham, Torkamani, Scherba, Ben-
son, Milton, Baldwin, Andersen, Schork,
Steinberg and Perls. This is an open-
access article distributed under the terms
of the Creative Commons Attribution
Non Commercial License, which per-
mits non-commercial use, distribution,
and reproduction in other forums, pro-
vided the original authors and source are
credited.
www.frontiersin.org January 2012 | Volume 2 | Article 90 | 15
Sebastiani et al. Whole genome sequences of supercentenarians
APPENDIX
FIGUREA1 | Schematic of the mapping/alignment and variant calling
steps.We used the Eland and BWA aligners to map reads to the reference
genome, and CASAVA and SAMTools to call SNPs as explained in Section
“Materials and Methods.” Short insertion and deletions were called using
SAMTools and Dindel. Only variants that were called by both algorithms and
passed quality control ﬁlters were included in the follow-up analyses.
FIGUREA2 | (A) Number of SNPs called by both SNP callers, the CASAVA
algorithm and SAMTools, with >99% concordant genotype calls, by
chromosome. (B) Distribution of Phred scores in SNPs called in PG17 and
PG26 (From SAMTools). (C) Distribution of reads used for SNPs calling in
PG17 and PG26 (From CASAVA). The median number of used reads was 36
in PG17 and 43 in PG26.
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FIGUREA3 | Plot of the B allele frequency (a measure of
heterozygosity/homozygosity) and the log R ratio (a measure of signal
intensity that relates to copy number variations) using Illumina
BeadStudio.The plot of B allele frequency shows that there are signiﬁcant
stretches of homozygosity across many chromosomes (see red arrows).
However, this was not associated with a shift in log R ratio at these locations
suggesting that this was not due to big deletions but probably to inbreeding
of her ancestors with distant relatives that resulted in higher homozygosity.
Table A1 | Summary of sequencing and mapping using the Illumina aligner and the BWA aligner.
Illumina report (hg18) BWA (hg18)
Male >110 Female >110 Male >110 Female >110
No of reads 1,804,595482 1,650,463,996 1,804,595,182 1,650,463,996
Read length 100 100 100 100
Number of bases used to generate consensus 114,850,993,633 98,120,678,830 156,017,244,672 133,347,354,219
Base pairs reported (consensus) 2,736,567,883 2,699,489,763 2,855,361,624 2,828,277,701
Number aligned reads 1,430,677,828 (79.3%) 1,246,883,285 (75.5%) 1,559,315,652 (86.41%) 1,334,406,235 (80.85%)
Rate of genome covered 0.957 0.952 0.999 0.998
Coverage depth 43.14 36.40 54.60 47.04
The parameters used with the aligner algorithms are in the Section “Materials and Methods.”
www.frontiersin.org January 2012 | Volume 2 | Article 90 | 17
Sebastiani et al. Whole genome sequences of supercentenarians
FIGUREA4 | Plot of the B allele frequency and the log R ratio in PG26.The plot of B allele frequency shows that there are no large structural variations.
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FIGUREA5 |Trends in QC parameters.We evaluated the effect of tighter
thresholds on the minimum coverage (=number of reads) on the transition
to transversion ratio (A), the heterozygous to homozygous ratios (B) and
the mean depths (C). The quality parameters appear to be stable for
different thresholds on minimum coverage.
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FIGUREA6 | Cumulative distributions of depth.The plots show the cumulative distributions of SNPs with coverage < values in the x -axes. For example,
80% of the reads in PG17 have more than 20-fold coverage.
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FIGUREA7 | Distribution of coverage and Phred scores of indels.
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FIGUREA8 | Functional analysis of the insertions detected in PG17 and PG26, their union and intersection.The chart in maroon shows the breakdown of
insertions and the rate of coding insertions in PG17 and PG26. The chart in orange shows the summary of insertions in nine whole genomes generated from
complete genomics and annotated in the same way as PG17 and PG26.
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FIGUREA9 | Functional analysis of the deletions detected in PG17 and PG26, their union and intersection.The chart in maroon shows the breakdown of
deletions and the rate of coding deletions in PG17 and PG26. The chart in orange shows the summary of deletions in nine whole genomes generated from
complete genomics and annotated in the same way as PG17 and PG26.
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FIGUREA10 | Population structure of the two supercentenarians.The two
scatter plots display the principal components 1 and 2 (PCI and 2 PC2, top
panels), and principal components 3 and 4 (PC3 and PC4, bottom panels) in
801 subjects from the NECS that were estimated using genome-wide data.
We colored the points by one of 16 ancestral groups that were inferred using
an algorithm described in Solovieff et al. (2010). The clusters were then
labeled by ethnicity using the information about mother tongue and place of
birth of NECS subjects and their parents. Based on the coordinates of the
PCs of two subjects in the plots, we conﬁrmed that the female had a mixed
French/British ancestry, while the males had mainly a Germanic ancestry.
FIGUREA11 | Genomic Coverage from ELAND. Barplots show the % of genomic coverage per chromosome when the reads were mapped to HG18 using
the Illumina Elander aligner.
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Table A2 | List of genome sequences that were used for comparisons with PG17 and PG26.
Genome Ethnicity Gender Platform Reference
NA12891 CEU M Illumina http://www.nature.com/nature/journal/v467/n7319/full/nature09534.html
NA12892 CEU F Illumina http://www.nature.com/nature/journal/v467/n7319/full/nature09534.html
NA12878 CEU F ABI_SOLiD http://www.yandell-lab.org/publications/pdf/ten_genomes_analysis.pdf
NA12878 CEU F Illumina http://www.nature.com/nature/journal/v467/n7319/full/nature09534.html
YH Chinese M Illumina http://www.nature.com/nature/journal/v456/n7218/full/nature07484.html
AK1 Korean M Illumina http://www.nature.com/nature/journal/v460/n7258/full/nature08211.html
NA07022 CEU M Complete genomics http://www.completegenomics.com/sequence-data/data-summary/
NA20431 CEU M Complete genomics http://www.completegenomics.com/sequence-data/data-summary/
NA19240 AA F Complete genomics http://www.completegenomics.com/sequence-data/data-summary/
NA19240 AA F ABI_SOUD http://www.yandell-lab.org/publications/pdf/ten_genomes_analysis.pdf
NA18507 AA M Illumina http://www.nature.com/nature/journal/v456/n7218/full/nature07517.html
NA18507 AA M ABI_SOLiD http://www.yandell-lab.org/publications/pdf/ten_genomes_analysis.pdf
Quake CEU M Helicos http://www.nature.com/nbt/journal/v27/n9/abs/nbt.1561.html
Venter CEU M Sanger http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0050254
Watson CEU M Roche 454 http://www.nature.com/nature/journal/v452/n7189/full/nature06884.html
PG17 CEU F Illumina
PG26 CEU M Illumina
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Table A5 | Predicted functions (TFBS and miRs).
PG17
(all SNPs)
PG26
(all SNPs)
PG17
(all ins)
PG26
(all ins)
PG17
(all del)
PG26
(all del)
miRNA
Total number of variants creating miRNA binding sites 5,965 6,150 208 241 265 298
Total number of variants destroying miRNA binding sites 6,007 6,267 298 320 197 192
Total number of variants perturbing miRNA binding sites (diff
deltaG>0)
13,190 13,655 880 938 808 877
TFB
Total number of TFBS disrupting variants 587,761 638,857 28,896 33,234 50,997 58,709
Total number of major TFBS disrupting variants
(dScore<−7)
4,037 4,619 7,560 9,005 30,123 35,117
Total number of TFBS deleting variants: 52 62 0 0 416 524
SPLICE
Total number of splice site variants 3,385 4,284 306 352 269 308
Total number of “splicing change” variants 23 28 85 104 102 129
Total number of variants creating exonic splicing enhancer
binding sites
6,628 7,240 39 66 189 200
SITES
Total number of variants destroying exonic splicing enhancer
binding sites
6,646 7,300 50 65 193 211
Total number of variants creating exonic splicing silencer
binding sites
3,738 4,038 38 43 176 179
Total number of variants destroying exonic splicing silencer
binding sites
3,607 3,982 14 23 158 153
The functional annotation was done with the complementary genome-wide variant annotation tools embedded in a suite of tools developed by researchers at The
Scripps Research Institute (see referenceTorkamani et al., 2011).
Table A6 | Rates of SNPs and indels that affect microRNAs and transcription factor binding sites (TFBS).
PG17
(all SNPs, %)
PG26
(all SNPs, %)
PG17
(all ins, %)
PG26
(all ins, %)
PG17
(all del, %)
PG26
(all del, %)
miRNA
Total number of variants creating miRNA binding
sites
0.19 0.19 0.12 0.13 0.16 0.16
Total number of variants destroying miRNA binding
sites
0.19 0.19 0.18 0.17 0.12 0.10
Total number of variants perturbing miRNA binding
sites (diff deltaG>0)
0.43 0.42 0.52 0.50 0.48 0.48
TFB
Total number of TFBS disrupting variants 19.05 19.63 17.01 17.77 30.24 32.04
Total number of major TFBS disrupting variants
(dScore<−7)
0.13 0.14 4.45 4.81 17.86 19.17
Total number of TFBS deleting variants 0.00 0.00 0.00 0.00 0.25 0.29
The functional annotation was done with the complementary genome-wide variant annotation tools embedded in a suite of tools developed by researchers at The
Scripps Research Institute (see referenceTorkamani et al., 2011).
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